1,498 results on '"Sieper, Joachim"'
Search Results
152. Histomorphologic and Histomorphometric Characteristics of Zygapophyseal Joint Remodeling in Ankylosing Spondylitis
153. Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
154. Response to H Zeidlerʼs comments on the INFAST study
155. Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis
156. Spinal Inflammation in the Absence of Sacroiliac Joint Inflammation on Magnetic Resonance Imaging in Patients With Active Nonradiographic Axial Spondyloarthritis
157. Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
158. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
159. Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials
160. Chapter 16 - Treatment Guidelines for Axial Spondyloarthritis
161. Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics
162. Implementing an Automated Monitoring Process in a Digital, Longitudinal Observational Cohort Study
163. Diagnosing axial spondyloarthritis: estimation of the disease probability in patients witha prioridifferent likelihoods of the diagnosis
164. Radiographic sacroiliitis progression in axial spondyloarthritis: central reading of 5 year follow-up data from the Assessment of SpondyloArthritis international Society cohort
165. Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility
166. Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial
167. Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
168. Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study
169. Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study
170. ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort
171. Diagnosing early ankylosing spondylitis
172. Treatment response to biological disease-modifying anti-rheumatic drugs is associated with favorable changes of the body composition in patients with ankylosing spondylitis
173. Depressive Symptomatik bei axSpA-Patienten ist mit hoher Krankheitsaktivität und schlechtem Funktionsstatus assoziiert: eine Querschnittsanalyse aus RABBIT-SpA
174. Impact of body composition measures on the response to biological disease-modifying anti-rheumatic drugs in patients with ankylosing spondylitis
175. Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort:discrepancies with local readers and impact on the performance of the ASAS criteria
176. Consensus definitions for MRI lesions in the spine of patients with axial spondyloarthritis: First analysis from the assessments in spondyloarthritis international society classification cohort
177. WHAT IS THE IMPACT OF DISCREPANCY BETWEEN CENTRAL AND LOCAL READERS IN EVALUATION OF MRI SCANS ON THE CLASSIFICATION OF AXIAL SPONDYLOARTHRITIS? DATA FROM THE ASAS CLASSIFICATION COHORT STUDY
178. Preliminary definition of a positive MRI for structural lesions in the sacroiliac joints in axial spondyloarthritis
179. WHAT IS THE IMPACT OF DISCREPANCY BETWEEN CENTRAL AND LOCAL READERS IN EVALUATION OF MRI SCANS ON THE CLASSIFICATION OF AXIAL SPONDYLOARTHRITIS?:DATA FROM THE ASAS CLASSIFICATION COHORT STUDY
180. Development and validation of an artificial intelligence approach for the detection of radiographic sacroiliitis
181. sj-pdf-3-tab-10.1177_1759720X20972610 – Supplemental material for The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study
182. Additional file 1 of The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study
183. sj-pdf-1-tab-10.1177_1759720X20972610 – Supplemental material for The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study
184. sj-pdf-2-tab-10.1177_1759720X20972610 – Supplemental material for The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study
185. sj-pdf-4-tab-10.1177_1759720X20972610 – Supplemental material for The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study
186. Ankylosing spondylitis
187. Sex differences in clinical phenotype and radiographic disease progression in axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort
188. Komorbiditäten sind mit einer höheren Krankheitsaktivität und einer stärkeren Funktionseinschränkung bei Patienten mit axialer Spondyloarthritis assoziiert
189. Association of clinical and radiographic phenotype of axial spondyloarthritis with skin psoriasis: results from the GErman SPondyloarthritis Inception Cohort
190. Longitudinal Assessment of MRI of the Sacroiliac Joints in the ASAS Classification Cohort: Evolution of Diagnostic Features and Predictive Utility for Axial Spondyloarthritis
191. Fluoroscopy-guided application of corticosteroids for local control of manubriosternal joint pain in patients with spondyloarthropathies
192. An elevated level of IL-10- and TGFβ-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritis
193. Disease mechanisms in reactive arthritis
194. Relation of α2-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis
195. Comparison of an online self-referral tool with a physician-based referral strategy for early recognition of patients with a high probability of axial spa
196. Role of Novel Biological Therapies in Psoriatic Arthritis: Effects on Joints and Skin
197. Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort (GESPIC)
198. In Situ Analysis of Interleukin–23– and Interleukin-12-Positive Cells in the Spine of Patients With Ankylosing Spondylitis
199. Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI
200. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.